NVO
CompareNovo Nordisk
Exchange: NYSESector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in DKK
Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.
Current Price
—
GoodMoat Value
$87.03
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Novo Nordisk (NVO) Stock Analysis
Market Cap—
Current Price—
P/E Ratio—
Forward P/E—
PEG Ratio—
EPS—
Book Value—
P/B Ratio—
NVO Financial Charts
Novo Nordisk (NVO) Financial Summary
Novo Nordisk (NVO) is a Healthcare company in the Biotechnology industry, listed on NYSE..
..
NVO Key Financial Metrics
| Metric | Value |
|---|
Novo Nordisk (NVO) Valuation
Based on GoodMoat's DCF model, Novo Nordisk has a fair value estimate of $87.03.
About Novo Nordisk
Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.